Can a daily antibiotic keep kids with leukemia safer from infection?
NCT ID NCT04678869
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving children with acute lymphoblastic leukemia a daily antibiotic called ciprofloxacin can reduce bacterial infections during the first month of chemotherapy. About 313 children in the UK are taking part. The goal is to see if this approach works better than standard care and to check for antibiotic resistance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA - CATEGORY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Addenbrookes Hospital
Cambridge, United Kingdom
-
Alder Hey Children's Hospital
Liverpool, United Kingdom
-
Bristol Royal Hospital for Children
Bristol, United Kingdom
-
Great Ormond Street Hospital
London, United Kingdom
-
John Radcliffe Hospital
Oxford, United Kingdom
-
Leeds General Infirmary
Leeds, United Kingdom
-
Leicester Royal Infirmary
Leicester, United Kingdom
-
Nottingham Children's Hospital
Nottingham, United Kingdom
-
Royal Aberdeen Children's Hospital
Aberdeen, United Kingdom
-
Royal Manchester Children's Hospital
Manchester, United Kingdom
-
Royal Victoria Infirmary
Newcastle, United Kingdom
-
Sheffield Children's Hospital
Sheffield, United Kingdom
-
Southampton General Hospital
Southampton, United Kingdom
-
Univeristy College Hospital London
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.